BioAge Labs, Inc.
NASDAQ:BIOABiotechnology
+$0.47 today
- Market cap
- $179.59M
- Beta
- 0.95
- P/E (TTM)
- -9.7
- EPS (TTM)
- -$2.12
Volume 0.64M
Average 0.46M
BIOA Property, Plant & Equipment (Net)
Physical long-term assets such as land, buildings, and machinery, net of accumulated depreciation.
BioAge Labs, Inc.NASDAQ: BIOA
Property, Plant & Equipment (Net) · Q1 FY2026 · quarter ended Mar 2026
Property, plant & equipment (net) falls 8.0% from a year ago
Property, plant & equipment (net) stood at $3.8M at the end of Q1 FY2026, down 8.0% from a year earlier and up 1.4% from the prior quarter. Over 3 fiscal years it compounded at +115.6% a year.
Context
- Property, plant & equipment (net) amounted to 1.0% of total assets at the end of Q1 FY2026, down 0.2 pp from a year earlier.
- Property, plant & equipment (net) increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether property, plant & equipment (net) keeps falling in the next quarterly balance sheet after a -8.0% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Property, Plant & Equipment (Net) history
USD · from the balance sheet
- Latest · FY2025
- 3.75M USD
- Year-over-year change
- +373.8%
- 3-year CAGR
- +115.6%
| Period | Period end | Property, Plant & Equipment (Net) | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 3.75M | +373.8% |
| FY2024 | 2024-12-31 | 791K | +52.7% |
| FY2023 | 2023-12-31 | 518K | +38.5% |
| FY2022 | 2022-12-31 | 374K | — |
Property, Plant & Equipment (Net) vs competitors
How BIOA compares with its peers on the latest reported figures
- Peers report in different currencies, so property, plant & equipment (net) is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of -8.0% is the 3rd highest of 9, against a peer median of -20.7%.
- Property, plant & equipment (net) amounts to 1.0% of total assets for BIOA, versus a peer median of 27.5%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | CA$316.49M CAD | +7.8% | -2.2% | 28.3% | |
| Dec 2025 | $127.3M USD | — | — | 54.8% | |
| Mar 2026 | CA$124.01M CAD | -53.5% | -27.3% | 20.6% | |
| Mar 2026 | $108.84M USD | -14.3% | -16.9% | 27.5% | |
| Mar 2026 | $54.13M USD | -10.0% | -7.8% | 54.9% | |
| Mar 2026 | $46.08M USD | +23.2% | -1.6% | 41.7% | |
| Mar 2026 | $20.56M USD | -27.0% | +40.6% | 13.9% | |
| Mar 2026 | $18.3M USD | -47.1% | -30.8% | 12.3% | |
BIOABioAge Labs, Inc. | Mar 2026 | $3.8M USD | -8.0% | +115.6% | 1.0% |
| Mar 2026 | $831K USD | -55.4% | -35.6% | 0.3% | |
| Peer median (excluding BIOA) | — | -20.7% | -12.4% | 27.5% | |
Competitors are the stored peer set for BIOA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
BioAge Labs, Inc.
NASDAQ:BIOA
Intrinsic Alpha fair value
Locked
Current Price
$4.77
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.